Teza Capital Management »

Corcept Therapeutics Incorporated shares owned by Teza Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Teza Capital Management from 13F filings

Historical chart of Teza Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Teza Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Teza Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $467k 4.1k 114.22
2024-12-31 $212k 4.2k 50.39
2024-03-31 $329k 13k 25.19
2023-12-31 $209k 6.4k 32.48
2023-09-30 $206k 7.6k 27.25
2023-06-30 $233k 11k 22.25
2020-06-30 $604k 36k 16.82
2019-12-31 $449k 37k 12.09

More positions owned by Teza Capital Management

Bank of America Corporation (BAC)
NVIDIA Corporation (NVDA)
Boston Scientific Corporation (BSX)
Schlumberger Com Stk (SLB)
Us Bancorp Del Com New (USB)
Ge Aerospace Com New (GE)
Truist Financial Corp equities (TFC)
Fifth Third Ban (FITB)
Morgan Stanley Com New (MS)
Chesapeake Energy Corp (EXE)
Micron Technology (MU)
Lam Research Corp Com New (LRCX)
AFLAC Incorporated (AFL)
Key (KEY)
Progressive Corporation (PGR)

View all positions for Teza Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated